Folitrax 20MG Injection (1ml) is a pharmaceutical preparation containing Methotrexate, a potent antimetabolite and immunosuppressant agent. This medication is primarily used in the treatment of various conditions, including certain types of cancer, autoimmune diseases, and ectopic pregnancies. Methotrexate works by inhibiting the metabolism of folic acid, which is essential for DNA synthesis and cell division. The injection form allows for direct administration into the bloodstream, ensuring rapid absorption and effectiveness. Folitrax is often prescribed in a controlled medical setting, where healthcare professionals can monitor its effects and adjust dosages as necessary. The composition of Folitrax 20MG Injection includes Methotrexate at a concentration of 20mg per 1ml, making it a concentrated option for patients requiring this specific dosage. Overall, Folitrax serves as a critical component in the management of serious health conditions, providing significant therapeutic benefits when used appropriately.

Folitrax 20MG Tablet (4’s) is a medication that contains Methotrexate, a potent antimetabolite and immunosuppressant agent, primarily used in the treatment of various autoimmune diseases and certain types of cancer. Each tablet contains 20 mg of Methotrexate, which works by inhibiting the metabolism of folic acid, thereby interfering with DNA synthesis and cell replication. This mechanism makes Folitrax effective in managing conditions such as rheumatoid arthritis, psoriasis, and certain malignancies like leukemia and lymphoma. The drug is typically prescribed as part of a comprehensive treatment plan, and its use requires careful monitoring due to its potential side effects and interactions with other medications. Patients should be aware of the importance of adhering to prescribed dosages and schedules to maximize therapeutic benefits while minimizing risks.